Theriva Biologics

TOVXNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.425 M

$0.16 -14.84%

Close of 6 Nov 2026

As of 6 Nov 2026, Theriva Biologics (TOVX) has a market capitalization of $7.43M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$23.7M

Loss-making

Shares outstanding

45,892,668

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#427Alaunos TherapeuticsTCRT$7.51M
#428Tempest TherapeuticsTPST$7.51M
#429Theriva BiologicsTOVX$7.43M
#430Alzamend NeuroALZN$7.38M
#431Vistagen TherapeuticsVTGN$7.37M

What if Theriva Biologics were worth as much as…

Open the what-if tool →

Gold $28.2T

$615,280.69

Per share 3,802,724× higher

Bitcoin $1.53T

$33,291.77

Per share 205,759× higher

Apple $5.02T

$109,293.76

Per share 675,487× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Theriva Biologics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.